Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.62 DKK | +2.88% | -0.49% | -17.14% |
Mar. 27 | EU Commission Green-lights Lundbeck, Otsuka's Abilify Maintena as Maintenance Treatment of Schizophrenia | MT |
Mar. 20 | H. Lundbeck A/S Announces Management Appointments | CI |
Sales 2024 * | 20.95B 3.03B | Sales 2025 * | 21.83B 3.16B | Capitalization | 32.04B 4.64B |
---|---|---|---|---|---|
Net income 2024 * | 2.98B 431M | Net income 2025 * | 3.41B 493M | EV / Sales 2024 * | 1.32 x |
Net cash position 2024 * | 4.4B 637M | Net cash position 2025 * | 8.03B 1.16B | EV / Sales 2025 * | 1.1 x |
P/E ratio 2024 * |
11.1
x | P/E ratio 2025 * |
9.64
x | Employees | 5,681 |
Yield 2024 * |
2.65% | Yield 2025 * |
3.05% | Free-Float | 30.83% |
Latest transcript on Lundbeck
1 day | +2.88% | ||
Current month | -17.14% | ||
Current year | -17.14% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 28.62 | +2.88% | 163,332 |
24-03-26 | 27.82 | -0.50% | 82,884 |
24-03-25 | 27.96 | +0.58% | 99,297 |
24-03-22 | 27.8 | -1.42% | 127,612 |
24-03-21 | 28.2 | -1.95% | 69,660 |
Delayed Quote Nasdaq Copenhagen, March 27, 2024 at 11:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.48% | 70.86B | |
+11.65% | 27.37B | |
-1.96% | 8.14B | |
+1.91% | 7.92B | |
-25.23% | 7.51B | |
+10.56% | 4.08B | |
+3.02% | 4.12B | |
-4.65% | 3.92B | |
+11.60% | 3.33B |
- Stock
- Equities
- Stock H. Lundbeck A/S
- Stock Lundbeck - Nasdaq Copenhagen